ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma

Feng Ji, Peizhi Lu, Guangzhi Zhu, Shing Chuan Hooi, Yong Wu, Xiaowei Huang, Hui-Qi Dai, Pan-hong Chen, Zhongjie Li, Wenjing Su, Chuangye Han, Xinping Ye, Tao Peng, Jing Zhou, Guo‐Dong Lu